Sign in

NCT05693922Completed

Augmenting Single-session Behavioral Activation (BA) With Delta-beta Transcranial Alternating Current Stimulation (tACS) for the Treatment of Depression

Source: ClinicalTrials.gov · Last updated 20 May 2025

Brief summary (registry, in English)

Investigating whether delta-beta cross-frequency transcranial alternating current stimulation can augment the effects of a single session of behavioral activation in participants with major depressive disorder.

Status (registry)
Completed
Study type
Interventional
Enrollment
30 (actual)
First submitted
11 Jan 2023
Start date
9 Feb 2023
Primary completion date
22 May 2024
Lead sponsor
University of North Carolina, Chapel Hill
Diseases
Depression
NCT number
NCT05693922

What you commit to

  • Study type: Interventional
  • Participants enrolled: 30
  • From 9 Feb 2023 to the primary completion date, 22 May 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Participants may not currently be in psychotherapy and have not received any other psychotherapy and/or stimulation (ECT, TMS) within the last 4 weeks.
  • Any participants taking psychotropic medication must be on a stable dose for at least 4 weeks with no planned dose changes within the next 4 weeks.
  • Participants may not have undergone prior brain surgery
  • Participants may not have any brain devices/implants, including cochlear implants and aneurysm clips

Other illness

  • Participants must not meet criteria for current severe substance use disorder, anorexia nervosa, or active psychosis as captured by the MINI.
  • Participants may not have any medical or neurological illness for which symptom presentation or treatment could interfere with study participation
  • Participants may not have a history of brain injury requiring current treatment

Other

  • Participants must not have active suicide intent as determined by the Columbia Suicide Severity Rating Scale (C-SSRS). Active suicide intent will be captured in responses to items 4 and/or 5 on the C-SSRS.
  • (for female participants) Participants must not be pregnant or breastfeeding.
  • Participants may not have had brain injury or concussion within the last three months

Who the study is looking for

  • 18 years old or order
  • Able to provide informed consent
  • Willing to comply with all study procedures and be available for the duration of the study
  • Speak and understand English
  • DSM-5 diagnosis of major depressive disorder (MDD) as assessed by the MINI

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University of North Carolina at Chapel Hill
Coordinator of this site? Confirm its status
Chapel HillUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.